# nanosynth Group confident about the near term prospects of the business

- Link: https://www.directorstalkinterviews.com/nanosynth-group-confident-about-the-near-term-prospects-of-the-business/4121084700
- Published: 2022-09-30T07:12:00+01:00
- Author: Amilia Stone

**nanosynth group plc** (LON:NNN), the AIM quoted company specialising in the synthesis
and application of nanoparticles to create new and improve existing products, has
presented its unaudited half yearly report for the six-month period ended 30 June
2022.

**Operational highlights for the period:**

·      Successful trial results with Volz Holdings and REACH UK registration

o  Creating potential to lead to wider adoption by the global filtration industry

o  Pipeline of interest is already at an advanced stage

·      Joint development agreement with a global wellness company for their first
project in the cosmetics market

o  On successful completion, opportunity to enter into an exclusive commercial agreement
for the supply of nanoparticles for this cosmetics market

·      New share subscription agreement to raise £2,942,500

o  Proceeds to be used primarily to fund its working capital requirements as the
Group looks to commercialise its bespoke nanoparticle technology

·      Directors continue to purchase shares in the Company

o  Confidence in considerable potential of the Group’s nanoparticle technology

·      Strengthened Board

o  New board members enhance commercial expertise and corporate governance

> **Mark Duffin, nanosynth Chief Executive Officer commented:**
> “We are pleased with the recent updates that we have been able to share as a result
> of the hard work especially during the last 12 months.  The REACH UK registration
> will allow our partner Volz to apply antiviral technology to all their products.
> This has the potential to lead to wider adoption by the global filtration industry.
> The first project in our R&D programme that was secured is a testimony to our 
> leadership in the nanotechnology market.  Confidentiality and competitive advantage
> remain our priority during the development stage and we look forward to potentially
> becoming exclusive partners in the future. The funding arrangements with Lanstead
> provide further working capital as the Group looks to commercialise its bespoke
> nanoparticle technology.
> “As a result, we are very excited about the future of the business and are confident
> about the near term prospects of the business.”

Share on: